83802-88-4

Upstream product

• 930-68-7 cyclohexenone 
• 873-55-2 sodium benzenesulfonate 
• 35155-84-1 3-phenylthiocyclohexanone 
• 201230-82-2 carbon monoxide 

Downstream Products

• 196790-46-2 (1S,3R)-3-(phenylsulfonyl)cyclohexanol 
• 65288-09-7 3-Benzenesulfonyl-cyclohexanol 
• 83802-89-5 1,1-(ethylenedioxy)-3-(phenylsulfonyl)-cyclohexane 
• 210886-51-4 1,1-(ethylenedioxy)-3-(10-hydroxydecyl)-3-(phenylsulfonyl)-cyclohexane 

Relevant academic research and scientific papers

Phase-Vanishing Methodology for Efficient Bromination, Alkylation, Epoxidation, and Oxidation Reactions of Organic Substrates

(Matrix presented) In cases where both reactants in a phase-vanishing reaction are less dense than the fluorous phase, an alternative to the U-tube method is to employ a solvent with greater density than the fluorous phase, such as 1,2-dibromoethane. This modification has been successfully applied to the methylation of a phenol derivative with dimethyl sulfate and to the m-CPBA-induced epoxidation of alkenes, N-oxide formation from nitrogen-containing compounds, and S-oxide or sulfone formation from organic sulfides.

Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder

The present invention provides preventive and/or therapeutic agents for either one, or both, of a diabetic vascular disorder and a diabetic respiratory disorder comprising, as an active ingredient, a cyclohexenone long chain alcohol compound represented b

THERAPEUTIC AGENT FOR SENSORY ABNORMALITY

The present invention provides therapeutic agents for sensory disorders represented by the following formula (1): [wherein R1, R2, and R3 each represent a hydrogen atom or a methyl group, and X represents a linear or branc

Cascade radical carbonylations leading to 3-substituted cyclohexanones

Tin radical mediated [5+1]-annulation methods leading to 3-substituted cyclohexanones were investigated. Cyclohexanones having a quaternary center at the 3-position were synthesized in good yields by allyltin-mediated three- and four-component cascade rea

Cyclohexenone long-chain alcohol and medicament containing same

Described is a cyclohexenone long-chain alcohol represented by the formula (1): wherein R1, R2 and R3 each independently represents a hydrogen atom or a methyl group and X represents a C10-18 alkylene or alkenylene group. The cyclohexanone long-chain alco

Cyclohexenonic long-chain fatty alcohols as neuronal growth stimulators

Neurotrophic factors play an important role in the development and maintenance of neurons, thus providing a suitable therapeutic approach for the treatment of neurodegenerative diseases. However, their clinical use has revealed problematic because of a number of technical and biological disadvantages. Among the different strategies proposed to overcome such difficulties, the search for non-peptide substances with neurotrophic potential is giving promising results. Here we will expose major findings in this field, drawing special attention to cyclohexenonic long-chain fatty alcohols, a novel family of compounds that promote neuronal survival and neurite outgrowth.

Facile nucleophilic substitution of 3-tert-butyldimethylsilyloxyalk-2-enylphosphonium salts

Phosphoniosilylation of a,β-enones with TBSOTf and triphenylphosphine at 0 °C affords 3-tert-butyldimethylsilyloxyalk-2-enylphosphonium salts, which undergo facile nucleophilic substitution with various nucleophiles to give 3-substituted silyl enol ethers

Effect of cyclohexenonic long chain fatty alcohols on neurite outgrowth. Study on structure-activity relationship

Four series of long chain fatty alcohols bearing a cyclohexenone moiety in addition to a ω-alkanol side chain were synthesized using 'Umpolung' reactivity strategy. Their effect on neurite outgrowth was evaluated by means of fetal rat neurons in culture. The length of the ω-hydroxy side chain is a crucial factor for biological activity.